North America Heart Valve Devices Market
市场规模（十亿美元）
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
USD 10,579.02 |
 CAGR |
% |
| Major Markets Players |
北美心脏瓣膜设备市场，按产品类型（机械心脏瓣膜、生物心脏瓣膜和经导管瓣膜）、治疗（开放手术和微创手术 (MIS)）、最终用户（医院和诊所、门诊手术中心、心脏中心、研究中心等）、分销渠道（直接招标、第三方分销商）划分的行业趋势及预测到 2030 年。
北美心脏瓣膜设备市场分析与洞察
心脏瓣膜装置用于治疗阻塞的心脏瓣膜，植入这些装置是最常见的手术之一。市场上的结构性心脏瓣膜装置包括机械瓣膜、生物瓣膜和经导管瓣膜。由于全球心脏瓣膜手术数量的增加，北美心脏瓣膜装置市场在预测期内可能会稳步增长。北美心脏瓣膜装置市场的增长预计将受到结构性心脏装置和手术的发展推动，例如主动脉瓣膜、左心房封堵装置和组织或生物瓣膜。组织瓣膜已经彻底改变了心脏瓣膜装置市场。下一代心脏瓣膜手术提供低交付患者资料、更可控的手术、更好的瓣膜功能、减少瓣周反流、提高耐用性和降低成本。主要市场参与者的产品创新促进了市场的增长，使他们能够满足更大的患者群体并取得更好的临床结果。
Data Bridge Market Research 分析称，预计到 2030 年，心脏瓣膜设备市场价值将达到 105.7902 亿美元，预测期内复合年增长率为 13.6%。由于全球对心脏瓣膜设备的需求迅速增长，产品类型占据了市场中最大的类型细分市场。本市场报告还深入介绍了定价分析、专利分析和技术进步。
|
报告指标 |
细节 |
|
预测期 |
2023 至 2030 年 |
|
基准年 |
2022 |
|
历史岁月 |
2021（可定制为 2020 - 2015） |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按产品类型（机械心脏瓣膜、生物心脏瓣膜和经导管瓣膜）、治疗（开放手术和微创手术 (MIS)）、最终用户（医院和诊所、门诊手术中心、心脏中心、研究中心和其他）、分销渠道（直接招标、第三方分销商）。 |
|
覆盖国家 |
美国、加拿大、墨西哥 |
|
涵盖的市场参与者 |
雅培 (Abbott)、波士顿科学公司 (Boston Scientific Corporation) 或其附属公司、Artivion, Inc.、Edwards Lifesciences Corporation、美敦力 (Medtronic)、NeoVasc、Micro Interventional Devices Incorporated、XELTIS、TTK、Meril Life Sciences Pvt. Ltd、Foldax, Inc.、启明医疗 (杭州) 股份有限公司 (Venus Medtech (Hangzhou) Inc.)、Colibri Heart Valve 等等。 |
心脏瓣膜设备市场定义
心脏瓣膜对于确保血液在体内以正确的方向平稳流动是必不可少的。心脏瓣膜负责血液的持续流动和维持血压。如果它们不能正常工作，切断心脏会导致狭窄。心脏病通常包括几种严重影响心脏的疾病。随着心血管疾病患者数量的增加，心脏瓣膜的调节在过去十年中迅速增加。不稳定的生活方式、生活方式疾病、吸烟人口增加、人口老龄化、医疗保健质量的提高以及预测期内医疗保健报销的快速发展等因素加速了心脏瓣膜市场的增长。此外，心脏瓣膜的高成本和心脏植入物的感染风险可能是在上述预测期内可能减缓心脏瓣膜市场增长的原因。新兴经济体医疗业务方面的增长和基础工作正在推动医疗旅游业的增长，推动心脏瓣膜设备市场的发展。对治疗心脏异常的微创手术的需求大大增加。目前心脏瓣膜手术中自动化的应用，例如经导管主动脉瓣置换术 (TAVR)，已经让位于越来越多类似的手术。从老龄化人口比例的增加来看，人寿保险单的增加也有望促进心脏瓣膜市场的增长。
心脏瓣膜设备市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：
驱动程序
- 心脏瓣膜装置的创新可改善临床疗效
推出用于微创手术的新产品可能会推动北美心脏瓣膜设备市场的发展。组织瓣膜彻底改变了心脏瓣膜市场。下一代心脏瓣膜手术提供更少的输送曲线、更可控的放置、更好的瓣膜功能、更少的瓣膜反流、更高的耐用性和更低的成本。产品创新提升了心脏瓣膜设备市场参与者的增长前景，因为它可以治疗更多患者并获得更好的临床结果。尽管近年来取得了重大进展，但结构性介入心脏病学仍然是一个具有巨大潜力的新兴市场。
此外，智能设计、新技术和生物材料应用不断推动新产品开发的边界，确保这些设备在未来几年内处于介入产品创新的前沿。设计创新正在帮助市场参与者挖掘心脏瓣膜设备的盈利增长机会。
因此，随着心脏瓣膜装置创新的不断增加，北美心脏瓣膜装置市场的增长预计将得到推动。
- 各种心脏病发病率上升
心脏病发作和中风通常是急性事件，主要由阻塞导致血液流向心脏或大脑引起。在 COVID-19 大流行的第一年，心脏病和中风死亡人数分别增加了 5.8% 和 6.8%。然而，与年龄相关的心脏病和中风死亡人数分别增加了 1.6% 和 1.7%。最常见的原因是供应心脏或大脑的血管内壁脂肪沉积。中风可能是由脑血管出血或血栓引起的。这一趋势表明，由于人口增长和老龄化，心血管疾病的发病率可能会急剧上升。
此外，高糖尿病和高血压、高胆固醇和吸烟是心脏病的主要危险因素。大约一半的美国人（47%）至少有这三个风险因素之一。其他医疗状况和生活方式选择也会使人们面临更高的心脏病风险，包括不健康的饮食、缺乏运动和过量饮酒。
此外，心脏病发病率的上升预计将成为北美心脏瓣膜装置市场发展的推动力。
机会
- 提高对假肢的认识
假体是一种用于替换缺失的身体部位或改善身体部位功能的装置。在需要干预的天然瓣膜异常情况下，人工心脏瓣膜的使用越来越多。一般来说，它们可以分为机械心脏瓣膜、生物瓣膜和同种异体移植物。人工瓣膜的目标是在血液动力学上像天然瓣膜一样起作用，同时将副作用降至最低。心血管假体装置已被开发用于替换受损的心脏组织。这些医疗设备旨在模仿正常心血管器官的功能。人工心脏使心脏外科医生能够增加对心脏传导阻滞的治疗。
此外，人工瓣膜的患病率为 1,000 岁以上人群中每 1,000 人中有 0.2 人，而 2,000 岁以下人群中每 1,000 人中有 5.3 人。
因此，人们对假肢认识的不断提高为市场的增长提供了机会。
克制/挑战
- 设备生产成本昂贵
在美国，接受主动脉瓣疾病治疗的患者数量正在快速增长。经导管主动脉瓣置换术 (TAVR) 取代了外科主动脉瓣置换术 (SAVR) 和药物治疗 (MT)。这些趋势的经济后果尚不清楚。因此，TAVR 的总成本高于 SAVR，并且比单独的 MT 昂贵得多。TAVR 成本随着时间的推移而下降，而 SAVR 和 MT 成本保持不变。
此外，TAVI手术费用高主要是因为制作成本高，但由于住院时间较短，非手术TAVI费用比AVR低。单单TAVI植入套件（瓣膜、球囊、鞘管）的费用就高达32500美元，而手术瓣膜仅需5000美元左右，就如在瑞士，TAVI植入套件费用约为32000法郎（约合35000美元），而生物手术假体费用约为3000瑞士法郎（约合3300美元）。根据合并症和并发症不同，美国的报销金额在0,000美元到5,000美元之间，瑞士的TAVI约为72,000法郎（78,000美元），AVR约为3,000法郎（7,000美元），这对于医院来说意味着经济损失。
因此，设备生产成本的上升可能会阻碍市场的增长。
最新动态
- 2023 年 9 月，雅培发布了五项后期演示的数据，展示了其微创设备在治疗各种结构性心脏病患者方面的优势。这些数据包括支持 MitraClip™ 价值的发现。它是世界上第一个也是领先的经导管边缘到边缘修复 (TEER)，用于治疗二尖瓣反流 (MR) 患者的漏瓣。在波士顿举行的心血管研究基金会第 34 届年度经导管心血管治疗 (TCT) 科学研讨会上，雅培结构性心脏疗法的新数据被公布。这有助于该公司提高其在市场上的业务地位。
- 2020年9月，波士顿科学公司宣布在欧洲引入ACURATE neo2™主动脉瓣系统。该新一代经导管主动脉瓣植入（TAVI）技术是一个新平台，具有多项功能设计，可提高原有ACURATE新平台的临床性能。与上一代相比，ACURATE neo2瓣膜系统扩大了主动脉瓣狭窄患者的适应症。这有助于该公司获得其产品组合。
心脏瓣膜设备市场范围
心脏瓣膜设备市场细分为产品类型、治疗、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
按产品类型
- 机械心脏瓣膜
- 生物心脏瓣膜
- 经导管瓣膜
根据产品类型，心脏瓣膜装置市场分为机械心脏瓣膜、生物心脏瓣膜和经导管瓣膜。
治疗方式
- 开放手术
- 微创手术
根据治疗方法，心脏瓣膜装置市场分为开放手术和微创手术。
由最终用户
- 医院和诊所
- 门诊手术中心
- 心脏中心
- 研究中心
- 其他的
根据最终用户，心脏瓣膜装置市场分为医院和诊所、门诊手术中心、心脏中心、研究中心和其他。
按分销渠道
- 直接招标
- 第三方分销商
根据分销渠道，心脏瓣膜装置市场分为直接招标和第三方分销商。
北美心脏瓣膜设备市场区域分析/见解
对心脏瓣膜装置市场进行分析，并提供市场规模信息，包括产品类型、治疗方法、最终用户和分销渠道。
本市场报告涵盖的国家包括美国、加拿大、墨西哥。
由于研发投入不断增加，北美占据了市场主导地位。由于主要参与者的强大影响力，美国在北美地区占据主导地位。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了北美品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战，以及销售渠道的影响。
竞争格局和心脏瓣膜设备市场份额分析
心脏瓣膜设备市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和宽度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对心脏瓣膜设备市场的关注有关。
心脏瓣膜设备市场的一些主要参与者包括雅培、波士顿科学公司或其附属公司、Artivion, Inc.、爱德华生命科学公司、美敦力、NeoVasc、Micro Interventional Devices Incorporated、XELTIS、TTK、Meril Life Sciences Pvt. Ltd、Foldax, Inc.、启明医疗（杭州）有限公司、Colibri Heart Valve 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA HEART VALVE DEVICES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 SOURCE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
3.1 EPIDEMIOLOGY
3.2 PESTEL ANALYSIS
3.3 PORTER'S FIVE FORCE
4 MARKET OVERVIEW
4.1 DRIVERS
4.1.1 INNOVATIONS IN HEART VALVE DEVICES OFFER IMPROVED CLINICAL OUTCOME
4.1.2 RISING NUMBER OF VARIOUS HEART DISEASES
4.1.3 ADVANCEMENTS IN TRANSCATHETER VALVE TECHNOLOGY
4.1.4 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES
4.2 RESTRAINTS
4.2.1 HIGH COST ASSOCIATED WITH THE SURGERIES
4.2.2 COMPLICATIONS ASSOCIATED WITH HEART VALVE REPLACEMENT
4.3 OPPORTUNITIES
4.3.1 INCREASING AWARENESS OF PROSTHETIC DEVICES
4.3.2 RISING PREVALENCE OF STROKE & CARDIAC ARREST TO REINFORCE DEMAND FOR HEART VALVE DEVICES
4.3.3 INCREASING FDA APPROVALS OF TRANSCATHETER AORTIC VALVES
4.4 CHALLENGES
4.4.1 STRICT GOVERNMENT REGULATIONS
4.4.2 EXPENSIVE PRODUCTION COST OF EQUIPMENT
5 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE
5.1 OVERVIEW
5.2 MECHANICAL HEART VALVES
5.2.1 AORTIC VALVE
5.2.2 MITRAL VALVE
5.3 BIOLOGICAL HEART VALVES
5.3.1 AORTIC VALVE
5.3.2 MITRAL VALVE
5.3.3 PULMONARY VALVE
5.3.4 TRICUSPID VALVE
5.4 TRANSCATHETER VALVE
5.4.1 AORTIC VALVE
5.4.2 MITRAL VALVE
5.4.3 PULMONARY VALVE
6 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT
6.1 OVERVIEW
6.2 MINIMALLY INVASIVE SURGERY (MIS)
6.2.1 CARDIAC VALVE REPLACEMENT
6.2.2 CARDIAC VALVE REPAIR
6.3 OPEN SURGERY
6.3.1 CARDIAC VALVE REPLACEMENT
6.3.2 CARDIAC VALVE REPAIR
7 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER
7.1 OVERVIEW
7.2 HOSPITAL & CLINICS
7.3 AMBULATORY SURGICAL CENTERS
7.4 CARDIAC CENTERS
7.5 RESEARCH CENTERS
7.6 OTHERS
8 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL
8.1 OVERVIEW
8.2 DIRECT TENDER
8.3 THIRD PARTY DISTRIBUTORS
9 NORTH AMERICA HEART VALVE DEVICES MARKET, BY REGION
9.1 NORTH AMERICA
9.1.1 U.S.
9.1.2 CANADA
9.1.3 MEXICO
10 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
11 SWOT ANALYSIS
12 COMPANY PROFILE
12.1 MEDTRONIC
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 EDWARDS LIFESCIENCES CORPORATION
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENTS
12.3 ABBOTT
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 BOSTON SCIENTIFIC CORPORATION OR ITS AFFILIATES.
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENT
12.5 ARTIVION, INC.
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 COLIBRI HEART VALVE
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENTS
12.7 FOLDAX, INC.
12.7.1 COMPANY SNAPSHOT
12.7.2 PRODUCT PORTFOLIO
12.7.3 RECENT DEVELOPMENTS
12.8 MERIL LIFE SCIENCES PVT. LTD.
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENTS
12.9 MICRO INTERVENTIONAL DEVICES, INCORPORATED.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENTS
12.1 NEOVASC
12.10.1 COMPANY SNAPSHOT
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 TTK
12.11.1 COMPANY SNAPSHOT
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 VENUS MEDTECH (HANGZHOU) INC.
12.12.1 COMPANY SNAPSHOT
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 XELTIS
12.13.1 COMPANY SNAPSHOT
12.13.2 PRODUCT PORTFOLIO
12.13.3 RECENT DEVELOPMENTS
13 QUESTIONNAIRE
14 RELATED REPORTS
表格列表
TABLE 1 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 5 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 6 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 7 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 9 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 11 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 13 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 14 NORTH AMERICA HOSPITALS & CLINICS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 NORTH AMERICA CARDIAC CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 NORTH AMERICA RESEARCH CENTERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 18 NORTH AMERICA OTHERS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 20 NORTH AMERICA DIRECT TENDER IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 NORTH AMERICA THIRD PARTY DISTRIBUTORS IN HEART VALVE DEVICES MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 NORTH AMERICA HEART VALVE DEVICES MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 23 NORTH AMERICA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 NORTH AMERICA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 25 NORTH AMERICA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 NORTH AMERICA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 NORTH AMERICA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 28 NORTH AMERICA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 29 NORTH AMERICA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 30 NORTH AMERICA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 31 NORTH AMERICA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 32 U.S. HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 33 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 34 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 35 U.S. MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 36 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 38 U.S. BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 39 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 41 U.S. TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 42 U.S. HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 43 U.S. MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 44 U.S. OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 45 U.S. HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 46 U.S. HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 47 CANADA HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 48 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 49 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 50 CANADA MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 51 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 52 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 53 CANADA BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 54 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 55 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 56 CANADA TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 57 CANADA HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 58 CANADA MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 59 CANADA OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 60 CANADA HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 61 CANADA HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 MEXICO HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 65 MEXICO MECHANICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 66 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 67 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 68 MEXICO BIOLOGICAL HEART VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 69 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 70 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 UNITS, (VOLUME)
TABLE 71 MEXICO TRANSCATHETER VALVES IN HEART VALVE DEVICES MARKET, BY PRODUCT TYPE, 2021-2030 ASP, (USD)
TABLE 72 MEXICO HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 73 MEXICO MINIMALLY INVASIVE SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 74 MEXICO OPEN SURGERY IN HEART VALVE DEVICES MARKET, BY TREATMENT, 2021-2030 (USD MILLION)
TABLE 75 MEXICO HEART VALVE DEVICES MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 76 MEXICO HEART VALVE DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA HEART VALVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA HEART VALVE DEVICES MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA HEART VALVE DEVICES MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA HEART VALVE DEVICES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA HEART VALVE DEVICES MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 NORTH AMERICA HEART VALVE DEVICES MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA HEART VALVE DEVICES MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA HEART VALVE DEVICES MARKET: SEGMENTATION
FIGURE 11 GROWING PREVALENCE OF VALVULAR DISEASES, SUCH AS AORTIC STENOSIS & AORTIC REGURGITATION, AND INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES ARE EXPECTED TO DRIVE THE NORTH AMERICA HEART VALVE DEVICES MARKET IN THE FORECAST PERIOD
FIGURE 12 MECHANICAL HEART VALVE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA HEART VALVE DEVICES MARKET IN 2023 & 2030
FIGURE 13 INCIDENDE AND PREVALENCE OF HEART VALVE OF NORTH AMERICA
FIGURE 14 INCIDENDE AND PREVALENCE OF HEART VALVE OF EUROPE
FIGURE 15 INCIDENDE AND PREVALENCE OF HEART VALVE OF ASIA-PACIFIC
FIGURE 16 INCIDENDE AND PREVALENCE OF HEART VALVE OF SOUTH AMERICA & MIDDLE EAST AND AFRICA
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE NORTH AMERICA HEART VALVE DEVICES MARKET
FIGURE 18 NORTH AMERICA HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2022
FIGURE 19 NORTH AMERICA HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 20 NORTH AMERICA HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 21 NORTH AMERICA HEART VALVE DEVICES MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA HEART VALVE DEVICES MARKET : BY TREATMENT, 2022
FIGURE 23 NORTH AMERICA HEART VALVE DEVICES MARKET : BY TREATMENT, 2023-2030 (USD MILLION)
FIGURE 24 NORTH AMERICA HEART VALVE DEVICES MARKET : BY TREATMENT, CAGR (2023-2030)
FIGURE 25 NORTH AMERICA HEART VALVE DEVICES MARKET : BY TREATMENT, LIFELINE CURVE
FIGURE 26 NORTH AMERICA HEART VALVE DEVICES MARKET : BY END USER, 2022
FIGURE 27 NORTH AMERICA HEART VALVE DEVICES MARKET : BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 NORTH AMERICA HEART VALVE DEVICES MARKET : BY END USER, CAGR (2023-2030)
FIGURE 29 NORTH AMERICA HEART VALVE DEVICES MARKET : BY END USER, LIFELINE CURVE
FIGURE 30 NORTH AMERICA HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 NORTH AMERICA HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 NORTH AMERICA HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 NORTH AMERICA HEART VALVE DEVICES MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 NORTH AMERICA HEART VALVE DEVICES MARKET: SNAPSHOT (2022)
FIGURE 35 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022)
FIGURE 36 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 NORTH AMERICA HEART VALVE DEVICES MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 NORTH AMERICA HEART VALVE DEVICES MARKET: BY PRODUCT TYPE (2023-2030)
FIGURE 39 NORTH AMERICA HEART VALVE DEVICES MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
